CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics

CytomX Therapeutics, Inc. (CTMX)

Today's Latest Price: $7.23 USD

0.27 (-3.60%)

Updated Jan 27 6:55pm

Add CTMX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CTMX Stock Summary

  • Of note is the ratio of CytomX Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 11.42% of US stocks have a lower such ratio.
  • Over the past twelve months, CTMX has reported earnings growth of 92.22%, putting it ahead of 88.62% of US stocks in our set.
  • Revenue growth over the past 12 months for CytomX Therapeutics Inc comes in at -19.2%, a number that bests just 10.03% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to CytomX Therapeutics Inc, a group of peers worth examining would be BCRX, ATHX, WVE, KALV, and RCUS.
  • Visit CTMX's SEC page to see the company's official filings. To visit the company's web site, go to
CTMX Daily Price Range
CTMX 52-Week Price Range

CTMX Stock Price Chart More Charts

CTMX Price/Volume Stats

Current price $7.23 52-week high $19.75
Prev. close $7.50 52-week low $5.10
Day low $7.22 Volume 240,000
Day high $7.47 Avg. volume 367,024
50-day MA $7.13 Dividend yield N/A
200-day MA $8.84 Market Cap 328.49M

CytomX Therapeutics, Inc. (CTMX) Company Bio

CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.

CTMX Latest News Stream

Event/Time News Detail
Loading, please wait...

CTMX Latest Social Stream

Loading social stream, please wait...

View Full CTMX Social Stream

CTMX Price Returns

1-mo -15.34%
3-mo 19.31%
6-mo -29.46%
1-year -54.78%
3-year -39.75%
5-year N/A
YTD -13.00%
2019 -44.97%
2018 -28.47%
2017 92.08%
2016 -47.34%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.4609 seconds.